Home Biosimilar Antibodies Apoptosis Others antibody lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) For research use only.
Not for use in humans.

lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262)

Synonyms: HGS-ETR 2, ETR2-ST01

Lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. MW : 145.5 KD.

lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262)

Purity & Quality Control

≥99

Biological Activity

Description Lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. MW : 145.5 KD.

Product Details

CAS No. 845816-02-6
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) | lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) supplier | purchase lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) | lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) cost | lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) manufacturer | order lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) | lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) distributor